Evidence map›Paper›PMID 36312280›Full record

ArticleFrontiers in cardiovascular medicine2022

Predictors of pregnancy-associated venous thromboembolism: A case-control study.

Mohammed A Alsheef, Alhanouf M Alabbad, Rowida A Albassam, Rawan M Alarfaj, Abdul Rehman Zia Zaidi, Ouhod A Alarfaj, Mohsen Ayyash, Amani Abu-Shaheen

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Reassessing the Risk of Venous Thromboembolism (VTE) Events in Women.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammed A AlsheefDepartment of Medical Specialties, King Fahad Medical City, Riyadh, Saudi Arabia.
Alhanouf M AlabbadCollege of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Rowida A AlbassamCollege of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Rawan M AlarfajCollege of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Abdul Rehman Zia ZaidiDepartment of Medical Specialties, King Fahad Medical City, Riyadh, Saudi Arabia.
Ouhod A AlarfajPharmacy Service Administration, King Fahad Medical City, Riyadh, Saudi Arabia.
Mohsen AyyashSchool of Mathematical Sciences, University Sains Malaysia (USM), Gelugor, Malaysia.
Amani Abu-ShaheenScientific Writing Department, King Fahad Medical City, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Venous thromboembolism (VTE), manifesting as pulmonary embolism (PE) or deep vein thrombosis (DVT), is the most common cause of morbidity and death during pregnancy and the postpartum period. We conducted this study to describe the predictors of pregnancy-associated VTE (DVT and PE). Methods: A case-control study was conducted at a tertiary care center in Riyadh. A total of 380 patients were included in this study, 180 of whom were diagnosed with pregnancy-associated thrombosis and 200 of them showed no VTE. Demographic data and data on risk factors of VTE were collected by reviewing the medical charts and the risk assessment tool of the Royal College of Obstetricians and Gynecologists, respectively. The main outcome measures were VTE, manifesting as PE or DVT. Results: The following factors were identified as the predictors of VTE through multivariate analysis: family history [Odds ratio (OR) = 50.47, 95% Confidence Interval (CI): 6.78-375.64, Conclusions: The findings of this study showed that family history, thrombophilia, and the presence of gross varicose veins were risk factors for VTE, exceeding other transient risk factors. Hence, prophylaxis is highly recommended for those women who present with any of these factors.

Indexed as

associated venous thromboembolismdeep vein thrombosisDVT and PEpregnancyVTE

Identifiers

PMID36312280
PMCPMC9614023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.